文献速递头痛与眩晕

偏头痛发作及异常性疼痛时多巴胺D2/D3失衡的活体研究

Dopamine D2/D3 imbalance during migraine attack and allodynia in vivo.
PubMed 文献 · Neurology · 2017-03-29

研究用[11C]雷氯必利PET比较8例发作性偏头痛患者与8例健康对照,患者分别在自发头痛发作期(静息及三叉神经热痛阈值挑战诱发异常性疼痛)和发作间期扫描。结果发现患者纹状体[11C]雷氯必利BPND在发作期及异常性疼痛时较发作间期显著升高,提示发作期内源性多巴胺释放减少且波动;静息期变化与病程正相关,挑战期与发作频率负相关。

要点

  • 偏头痛发作期纹状体[11C]雷氯必利BPND升高,提示内源性多巴胺释放减少。
  • 异常性疼痛时岛叶BPND突然降低,提示多巴胺释放波动。
  • 发作期多巴胺释放变化与偏头痛慢性化及发作频率相关。

核心结论

  • 偏头痛发作及发作性异常性疼痛时存在[11C]雷氯必利摄取失衡,提示发作期内源性多巴胺释放减少和波动。
  • 偏头痛病史越长、发作越频繁,发作期内源性多巴胺释放越低。

研究设计与样本

  • 研究纳入8例发作性偏头痛患者和8例健康对照,采用[11C]雷氯必利PET显像。
  • 患者接受两次PET扫描:一次在自发偏头痛发作期静息状态,随后进行三叉神经区域持续热痛阈值挑战诱发异常性疼痛;另一次在发作间期。

主要发现

  • 偏头痛患者纹状体[11C]雷氯必利BPND与健康对照无差异。
  • 偏头痛患者发作期及异常性疼痛时纹状体[11C]雷氯必利BPND较发作间期显著升高。
  • 与发作期静息相比,持续热痛阈值挑战时偏头痛患者岛叶[11C]雷氯必利BPND显著突然降低。
  • 健康对照在挑战时尾状核也观察到类似方向性变化(相对于发作间期)。
  • 发作期静息时[11C]雷氯必利BPND变化与偏头痛病程正相关,挑战时与发作频率负相关。

临床怎么用

  • 偏头痛发作期多巴胺D2/D3受体显像变化可能反映内源性多巴胺释放减少,提示多巴胺系统参与偏头痛发作及异常性疼痛机制。
  • 病程长、发作频繁的偏头痛患者发作期内源性多巴胺释放可能更低,提示疾病慢性化与多巴胺功能改变相关。

局限性

  • 样本量小(8例患者和8例对照),结论需更大样本验证。
  • 研究为观察性设计,无法确立多巴胺释放变化与偏头痛发作的因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate in vivo the dynamics of endogenous dopamine (DA) neurotransmission during migraine ictus with allodynia. METHODS: We examined 8 episodic migraineurs and 8 healthy controls (HC) using PET with [11C]raclopride. The uptake measure of [11C]raclopride, nondisplaceable binding potential (BPND), would increase when there was a reduction in endogenous DA release. The opposite is true for a decrease in [11C]raclopride BPND. Patients were scanned twice: one PET session was during a spontaneous migraine ictus at rest, followed by a sustained thermal pain threshold (STPT) challenge on the trigeminal region, eliciting an allodynia experience; another was during interictal phase. RESULTS: Striatal BPND of [11C]raclopride in migraineurs did not differ from HC. We found a significant increase in [11C]raclopride BPND in the striatum region of migraineurs during both headache attack and allodynia relative to interictal phase. However, when compared to the migraine attack at rest, migraineurs during the STPT challenge had a significant sudden reduction in [11C]raclopride BPND in the insula. Such directional change was also observed in the caudate of HC relative to the interictal phase during challenge. Furthermore, ictal changes in [11C]raclopride BPND in migraineurs at rest were positively correlated with the chronicity of migraine attacks, and negatively correlated with the frequency during challenge. CONCLUSIONS: Our findings demonstrate that there is an imbalanced uptake of [11C]raclopride during the headache attack and ictal allodynia, which indicates reduction and fluctuation in ictal endogenous DA release in migraineurs. Moreover, the longer the history and recurrence of migraine attacks, the lower the ictal endogenous DA release.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. DaSilva AF, Nascimento TD, Jassar H, et al. Dopamine D2/D3 imbalance during migraine attack and allodynia in vivo. Neurology. 2017. PMID: 28356463. doi:10.1212/WNL.0000000000003861

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。